Quantcast

Latest RNA interference Stories

2014-09-18 08:29:06

MARLBOROUGH, Mass., Sept. 18, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 7(th) Annual BioPharm America(TM) Conference on Wednesday, September 24, 2014 at 11:20 a.m. EDT. Dr....

2014-09-17 08:29:00

Patents granted by the United States Patent and Trademark Office and European Patent Office and a notice of allowance from the Japanese Patent Office broaden the breadth of the Company's delivery technology platform MARLBOROUGH, Mass., Sept. 17, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...

2014-09-11 12:27:04

SARASOTA, Fla., Sept. 11, 2014 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued a 'Notice of Allowance' for patent application 11/673,486 entitled 'Oligonucleotide-Containing Pharmacological Compositions And Their Uses'. The '486 patent application relates to the Company's orally-deliverable nanoRNA therapeutics that act through gene-silencing and can be...

2014-09-09 12:28:35

PORTLAND, Oregon, September 9, 2014 /PRNewswire/ -- A new report by Allied Market Research, titled "RNA Therapeutics Market (technology, applications, end user and geography) - Industry Analysis and Forecast, 2013 - 2020", suggests that the RNA Based Therapeutics Market would reach $1.2 billion by 2020 registering a CAGR of 28.4% during 2014 - 2020. Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain...

2014-09-08 08:29:41

BERGEN, Norway, September 8, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the United States Patent and Trademark Office (USPTO) has issued United States Patent 8,735,064 covering a method for creating and identifying functional interference RNA (RNAi) molecules (1). RNAis are recombinant nucleic acid molecules that have the ability to specifically down-regulate an expressed target gene in vivo....

2014-09-03 08:33:09

MARLBOROUGH, Mass., Sept. 3, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the Rodman & Renshaw 16(th) Annual Global Investment Conference on Wednesday, September 10, 2014 at 12:05 p.m. EST. Dr....

Researchers Identify MicroRNAs That Differentiate Male And Female Fruit Flies
2014-08-21 03:31:24

Cold Spring Harbor Laboratory Men and women differ in plenty of obvious ways, and scientists have long known that genetic differences buried deep within our DNA underlie these distinctions. In the past, most research has focused on understanding how the genes that encode proteins act as sex determinants. But Cold Spring Harbor Laboratory (CSHL) scientists have found that a subset of very small genes encoding short RNA molecules, called microRNAs (miRNAs), also play a key role in...

2014-08-04 08:27:10

MARLBOROUGH, Mass., Aug. 4, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company will ring the NASDAQ Stock Market closing bell on Friday, August 8, 2014. A live webcast will be available at https://new.livestream.com/nasdaq/live. Logo -...

2014-08-01 23:03:53

According to new report from BCC Research, the global market RNA interference (RNAi) drug delivery technologies is expected to grow to nearly $38.8 billion by 2018, with a five-year compound annual growth rate (CAGR) of 27.2%. The aptamer delivery category, the fastest moving segment of the market, is moving at a phenomenal 58.2% CAGR. Wellesley, Mass. (PRWEB) August 01, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, RNAi DRUG DELIVERY: TECHNOLOGIES AND GLOBAL...

New Mechanism Of Drug Resistance Discovered By Scientists
2014-07-29 03:47:02

Marla Vacek Broadfoot, Duke University Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs. These permanent mutations were once thought to be the only way for drug-resistant strains to evolve. Now a new study has shown that microorganisms can use a temporary silencing of drug targets -- known as epimutations -- to gain the benefits of drug resistance without the commitment. Though the new mechanism...


Latest RNA interference Reference Libraries

Blue Rose
2013-10-02 08:33:40

A Blue Rose is a flower of the genus Rosa belonging to the family Rosaceae that presents blue to violet pigmentation instead of the more common white, red, or yellow coloration. Blue roses are frequently portrayed in literature and art as a symbol of love and prosperity to those who seek it, but don’t exist in nature as a result of genetic limitations. In 2004, researchers utilized genetic modification to produce roses that contain the blue pigment delphinidin. After 13 years of...

Caenorhabditis elegans
2014-01-12 00:00:00

Caenorhabditis elegans is a species of parasitic roundworm in the Nematoda phylum. It can be found in temperate regions, in many different areas of the world. It prefers to reside in nutrient rich soils. Its scientific name is derived from the Greek terms Caeno, meaning recent, rhabditis, meaning rod-like, and the Latin term elegans, which means elegant. It was first named by Maupas in 1900, but was not classified in the Caenorhabditis subgenus until 1952 by Osche. Caenorhabditis elegans...

More Articles (2 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'